Chemotherapy and high-dose-rate brachytherapy in the management of advanced cancers of the nasopharynx: clinical impact of high techology - is it worth the cost?

Peter Levendag; Wideke Nijdam; M (Michel) van Agthoven; Carin Uyl - de Groot

doi:10.1016/S1538-4721(02)00005-3

Chemotherapy and high-dose-rate brachytherapy in the management of advanced cancers of the nasopharynx: clinical impact of high techology - is it worth the cost?

Peter Levendag, Wideke Nijdam, M (Michel) van Agthoven, Carin Uyl - de Groot

Research output: Contribution to journal › Article › Academic

9 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	11-20
Number of pages	10
Journal	Brachytherapy
Volume	1
DOIs	https://doi.org/10.1016/S1538-4721(02)00005-3
Publication status	Published - 2002

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1538-4721(02)00005-3

http://hdl.handle.net/1765/72590

Cite this

@article{b6c6add06b6342beb3aa42a238cb0c1b,

title = "Chemotherapy and high-dose-rate brachytherapy in the management of advanced cancers of the nasopharynx: clinical impact of high techology - is it worth the cost?",

author = "Peter Levendag and Wideke Nijdam and {van Agthoven}, {M (Michel)} and {Uyl - de Groot}, Carin",

year = "2002",

doi = "10.1016/S1538-4721(02)00005-3",

language = "Undefined/Unknown",

volume = "1",

pages = "11--20",

journal = "Brachytherapy",